Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Avista Pharma Solutions
Avista Pharma Solutions
Activities:
Manufacturing
Analysis
Microbiology
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Cambrex completes acquisition of Avista Pharma Solutions
Cambrex is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialisation of small molecule therapeutics
Manufacturing
Cambrex to acquire Avista Pharma Solutions
Deal adds early stage API and finished dosage form development & testing services to its global contract development & manufacturing network
Finance
Avista expands cleanroom and analytical test offering
Investment at the Agawam facility increases analytical chemistry footprint while new Boston office broader cleanroom services and courier business
Analysis
Avista Pharma Solutions completes expansion of US contract testing facility
The Massachusetts-based company has expanded its microbiology, sterility testing and microbial ID capabilities at the Agawam facility
Design & Build
Avista Pharma Solutions adds a microbiology laboratory at its Massachusetts facility
The CDMO will equip the lab with isolator technology for sterility testing and to increase the analytical footprint
Subscribe now